Loading...

  • Home
  • About
  • Solution
  • Team
  • Investors
  • Blog
  • Contact Us

Key Features

“Many within the healthcare community are struggling to keep up with medical device cybersecurity. I'm happy to see innovative startups like Medigate investigating solutions for this space.”

Billy Rios, Founder & CEO of WhiteScope, Medical Device Security Expert

“With the pandemic of cyberattacks targeting healthcare providers, this leaves far too many connect-ed devices vulnerable and exposed, putting patient health and privacy at risk. Medigate’s solution directly addresses this crucial problem by mitigating targeted attacks on medical devices”.

Yoav Leitersdorf, Managing Partner at YL Ventures, Lead Investor in Medigate

“Because it is not possible to effectively deploy endpoint security solutions and regular security patches to these devices, they significantly increase the exposure in my organization’s overall risk posture. A product like Medigate would add a much necessary layer of defense, significantly reducing the risk of medical device vulnerabilities to my networks.”

Heath Renfrow, Former U.S. Army Medicine CISO

“The team at Medigate has the right vision to help organizations safely connect devices to their networks and protect against cyber risk. Protecting devices at a network level is the only way to ensure success. Medigate is defining and leading the market for connected medical device security.”

Bruce Taragin, Managing Director at Blumberg Capital

Our Team

  • Jonathan Langer,Co-Founder & CEO

    Jonathan co-founded Medigate following 14 years of service in the Israeli Defense Forces Intelligence Corps working on design, incubation and analysis of key technological programs. In his last position, Jonathan served as branch leader commanding over 100 technical analysts involved in research of cyber related domains and was awarded the prestigious Israel Defense Award. Jonathan holds a LL.B from the Interdisciplinary Center in Herzliya.

  • Itay Kirshenbaum,Co-Founder & VP R&D

    Itay co-founded Medigate after serving in the Israeli Defense Forces Intelligence Technological Unit for the past 9 years in key cyber R&D positions. In his last position, Itay served as a prominent section leader commanding over 50 engineers working on cutting edge cyber R&D to achieve some of the most challenging technological projects of the Israeli Intelligence Corps. Itay holds a B.Sc in computer science from Tel-Aviv University.

  • Pini Pinhasov,Co-Founder & VP Product

    Pini is a graduate of the elite Talpiot military program and possesses 12 years of experience in the cybersecurity domain. Pini served as an officer in the Israeli Defense Forces Intelligence, Unit 8200, for the past 9 years. In his last position Pini commanded one of Unit 8200’s most sophisticated R&D sections, overseeing 35 top security researchers. Pini managed highly complex technical programs combining multi-disciplinary development teams. Pini holds a B.Sc in Physics and Mathematics from the University of Jerusalem.


Our Investors

  • YL Ventures is a Silicon Valley-based, seed-stage venture capital firm that invests in Israeli innovations with a strong focus on cybersecurity, enterprise software, autonomous vehicles, drone technologies and VR/AR. Currently investing out of its $75 million third fund, YL Ventures accelerates the evolution of portfolio companies via strategic advice and Silicon Valley-based operational execution.

  • Blumberg Capital is an early-stage venture capital firm that partners with passionate entrepreneurs to innovate and build successful technology companies. The firm specializes in leading Seed and Series A rounds collaborating with angel investors, other venture capital firms and strategic partners. The Blumberg Capital team are active investors and board members – operating as an extension of the entrepreneurs’ network. Blumberg Capital is headquartered in San Francisco with team members in Tel Aviv and New York.


Protect your hospital today.
Contact us for more information

Thank you for getting in touch!

Please enter your email
Send